2026 AGM Chair's Address and Presentation to Shareholders
Released
Released
Announcement PDF
Chair’s Address
2026 Annual General Meeting
Hearts and Minds Investments Limited ACN 628 753 220
A: 12.04A, Chifley Tower, 2 Chifley Square, Sydney NSW 2000. | W: HM1.com.au | E: ir@hm1.com.au | P: 1300 737 760 or +61 2 9290 9600
Thursday 19 November 2026
The Manager
ASX Market Announcements
ASX Limited
Exchange Centre
Level 27, 39 Martin Place
Sydney NSW 2000
Dear Shareholders,
Presentation and Chair’s Address at 2026 Annual General Meeting
In accordance with ASX Listing Rule 3.13.3, Hearts and Minds Investments Limited (ASX:
HM1) provides a copy of the address and presentation to be given at today’s Annual
General Meeting by HM1 Chair, Mr Chris Cuffe, on Thursday 19 November 2026.
For and on behalf of the board,
Natalie Climo
Company Secretary
Natalie Climo
Chair’s Address
2026 Annual General Meeting
Hearts and Minds Investments Limited ACN 628 753 220
A: 12.04A, Chifley Tower, 2 Chifley Square, Sydney NSW 2000. | W: HM1.com.au | E: ir@hm1.com.au | P: 1300 737 760 or +61 2 9290 9600
Hearts and Minds Investment Limited
Chair’s Address at 2026 Annual General Meeting
Good afternoon and welcome to the Annual General Meeting of Hearts and Minds
Investments Limited, or HM1. I am Chris Cuffe, Chair of the Company and of this meeting. It
is now the appointed time and, having been advised that a quorum is present, I declare
the meeting open.
Welcome to shareholders here in Sydney and joining online through Lumi. I welcome my
fellow Directors and company officers: Lorraine Berends (also Chair of the Investment
Committee), Matthew Grounds, Michael Traill, Guy Fowler, Gary Weiss, Geoff Wilson, David
Wright (also Chair of the Conference Fund Manager Selection Committee), Richard Howes
(Managing Director), Charlie Lanchester (Chief Investment Officer), Maggie O’Neill (Chief
Operating Officer), Head of Finance - Tony Bofinger, and Company Secretary - Natalie
Climo. I also welcome Richard King from our auditors, Pitcher Partners Sydney, who will be
available for audit questions.
Investment Performance
HM1 is a listed investment company established in 2018 with the combined objective of
providing a concentrated global equities portfolio of the highest conviction ideas from
respected fund managers, whilst also supporting Australian medical research
organisations. It was borne out of the annual investment and philanthropic vision of the
Sohn Hearts & Minds Investment Leaders Conference founded in 2016.
For the year ended 30 June 2026, the portfolio returned 5.2% after expenses and before all
taxes. Since inception, the corresponding annualised return was 10.7% at 30 June 2026.
Total comprehensive income after tax was $29.6 million. Net assets ended the year at
$773.9 million, compared with $786.7 million a year earlier, after distributions to
shareholders. At 13 November, post-tax net tangible assets were $3.21 per share and the
share price was $2.90, an 8.7% discount. The Board remains focused on narrowing that
discount.
Chair’s Address
2026 Annual General Meeting
Hearts and Minds Investments Limited ACN 628 753 220
A: 12.04A, Chifley Tower, 2 Chifley Square, Sydney NSW 2000. | W: HM1.com.au | E: ir@hm1.com.au | P: 1300 737 760 or +61 2 9290 9600
Dividends
During FY26, shareholders received 18.5 cents per share in fully franked dividends:
comprising the 9-cent FY25 final dividend and the 9.5-cent FY26 interim dividend. The
FY26 final dividend of 10 cents per share was paid after year-end, on 15 October 2026. The
Board intends to increase dividends by 0.5 cents per share every six months for the
foreseeable future, subject to there being no sustained period of investment market
underperformance. Based on the current share price, the increased annualised dividend
represents a fully franked grossed-up dividend yield of 10.6%.
Investment in Medical Research
HM1 paid $11.4 million to medical research organisations during FY26. Collectively, since
2016, the Hearts & Minds Group has now donated over $100 million to medical research, a
milestone we were proud to celebrate at the recent Sohn Hearts & Minds conference in
Queenstown. Thank you to our fund managers, directors, committee members and
service providers who contribute pro bono or at reduced cost, and to our shareholders for
making this win-win-win model possible.
FY26 in Review
In October, we formally established the Hearts & Minds Group which now includes a
management company, Hearts & Minds Investment Management, to support HM1 and
other funds that share a combined purpose of providing strong returns for investors and
philanthropic support of medical research.
We have acquired the Third Link Growth Fund, a Fund of 10 Australian Equity funds, and
renamed it to the Hearts & Minds Australian Equities Fund or HM3. We have also launched
the Hearts & Minds Global Income Fund, a diversified Fund of six global private credit
managers across direct corporate lending, asset-based finance, and opportunistic credit
strategies.
As part of these changes, we reduced the overall costs to HM1 shareholders. Effective from
1 July 2026, “other fund expenses” are included within the 1.5% of NTA framework rather
than charged on top, reducing the effective management expense ratio from
approximately 1.85% pa to 1.50% pa. And as other funds in the Hearts & Minds Group grow,
this will reduce further to 1.30% pa.
We look forward to building on the strong foundations and expanding the Hearts & Minds
philanthropic platform. On behalf of the Board and management of Hearts and Minds, I
would like to thank you for your continued support of HM1.
2026 Annual General Meeting
Thursday 19 November 2026 · 4:00 pm AEDT
The Work Project · Quay Quarter Tower
Level 2, 50 Bridge Street, Sydney
Chris Cuffe AO
Chair
Lorraine BerendsAM
Director & Chair of IC
Guy Fowler OAM
Director & Co-Founder
MatthewGroundsAM
Director & Co-Founder
Michael Traill AM
Director
Dr Gary Weiss AM
Director & Co-Founder
Geoff Wilson AO
Director
DavidWright
Director
RichardHowes
Managing Director
Board of Directors
Charlie Lanchester
Chief Investment Officer
Maggie O’Neill
Chief Operating Officer
Tony Bofinger
Head of Financial
Control & Investment
Operations
RichardHowes
Managing Director
Executive Team
Company Secretary
Natalie Climo
Boardroom Limited
Board & Executive Team
2 Hearts& MindsInvestments
This presentation has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753
220) and is current as at 17 November 2026. Hearts and Minds Investments Limited operates
under a Corporate Authorised Representation (No. 1317870) from Capital Matters RE Services
Limited (AFSL No. 563036)
This presentation is not an offer or solicitation with respect to the purchase or sale of any
financial product or investment and is qualified in its entirety by any information memorandum
and other legal documentation that may subsequently be made available. Accordingly, this
presentation should not form the basis of any investment decision.
The information contained in this presentation is of a general nature only and does not purport
to be complete. It does not contain all the information which would be required in a prospectus
or other disclosure document prepared in accordance with the requirements of the
Corporations Act 2001 (Cth). Furthermore, this presentation has been prepared without taking
into account the investment objectives, financial situation or particular needs of any individual
person, or class of persons and does not constitute financial product advice.
This presentation may contain statements, opinions, projections, forecasts and other material
(forward looking statements), based on various assumptions. Those assumptions may or may
not prove to be correct and any information relating to past performance should not be relied
upon as an indication of future performance. Forward-looking statements include information
concerning growth, pricing, future strategic objectives, business prospects, industry or market
conditions, demand for and pricing of our products, regulatory developments and general
economic conditions. In addition, words such as “believes,” “expects,” “anticipates,” “intends,”
“plans,” “estimates,” “projects,” “forecasts,” and future or conditional verbs such as “will,” “may,”
“could,” “should,” and “would,” as well as all other statements that necessarily depend on future
events, are intended to identify forward-looking statements. Forward-looking statements are
not guarantees, and they involve risks, uncertainties and assumptions. None of Hearts and
Minds Investments Limited, its respective officers, employees, agents, advisers or any other
person named in this presentation makes any representation as to the accuracy or likelihood
of fulfilment of the forward looking statements or any of the assumptions upon which they are
based.
This document also contains references to certain intentions, expectations and
plans of Hearts and Minds Investments Limited. These intentions, expectations and
plans may or may not be achieved. They are based on certain assumptions which
may not be met or on which views may differ. Past performance information in
this presentation is given for illustrative purposes only and should not be relied
upon as (and is not) an indication of future performance.
To the extent permitted by law, Hearts and Minds Investments Limited and its
respective officers, employees, agents and advisers give no warranty,
representation or guarantee as to the accuracy, completeness or reliability of the
information contained in this presentation. Further, none of Hearts and Minds
Investments Limited or its respective officers, employees, agents and advisers
accepts, to the extent permitted by law, responsibility for any loss, claim,
damages, costs or expenses arising out of, or in connection with, this presentation.
Any recipient of this presentation should independently satisfy themselves as to
the accuracy of all information contained herein and seek independent financial
advice.
This presentation is provided to you strictly on a confidential basis and the
information contained herein must not be reproduced or redistributed in any
format without the express written consent of Hearts and Minds Investments
Limited.
Disclaimer
3 Hearts& MindsInvestments
High-conviction global investing
A concentrated global equities portfolio of the highest
conviction ideas from respected fund managers, whilst also
supporting Australian medical research.
HM1 at a glance
4 Hearts& MindsInvestments
Fund Managers
Contribute meaningfully to
philanthropy by sharing their talent,
time & best ideas for lasting social
impact.
Impact Partners
Receive a consistent stream of
funding, enabling flexibility, scale,
and the freedom to pursue bold
ideas. Hearts & Minds is on track to
donate $100m within its first
decade (2026).
Shareholders
Gain exclusive access to a
concentrated global equities
portfolio built from the highest
conviction ideas of selected fund
managers, many unavailable to
individual investors.
Hearts& Minds Investments (HM1)
Actively managed by the CIO and guided by
an experienced Investment Committee. NTA
c.$700m.
+5.2%
FY26 investment return
$29.6m
Total comprehensive income
after tax
$773.9m
Net assets at 30 June 2026
FY26 in Review
5 Hearts& MindsInvestments
+13.8%
Three-year investment return
+10.7%
Since inception investment return
to 30 June 2026
$3.21
Post-tax NTA at 13 Nov 2026
Share price $2.90 (8.7% discount)
6
7.0** 7 8.0 9.5
7.0 7.5
9.0
10.0*
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
16.0
18.0
20.0
22.0
FY23 FY24 FY25 FY26
Interim fully-franked dividends paid Interim fully-franked dividend payable
*Intended FY26 Dividends
10.6%
Fully Franked^
Expected 12-Month
Grossed-Up Dividend
Yield
Cash dividends
paid during FY26
18.5cps
Dividend Cents per share Payment Period
FY25 Final 9.0cps During FY26
FY26 Interim 9.5cps During FY26
FY26 Final 10.0cps 15 October 2026
Fully franked. Future dividends remain subject to profits, franking balances, Board discretion and market conditions. ^
Annualised fully franked dividend of 21.5cps divided by share price on 13 November 2026
Fully franked dividends since inception
Delivering strong investment returns
and fully-franked dividends
All figures as at 31 September 2026. *The Board of HM1 has resolved to increase dividends by 0.5 cps every 6 months for the
foreseeable future subject to there being no sustained period of investment market underperformance. **Prior to FY24, HM1
paid dividends annually. The dividend in April 2023 was 13.5 cps. For the purposes of this chart, we have allocated 7.0 cps to
the FY23 financial year. Prior dividends were 12.0 cps in April 2021 and 13.5 cps in April 2022.
14.0 14.5
17.0
19.5
Fully franked dividends
Dividend Paid
15 October 2026
10.0cps
Paid after year-end
Hearts& MindsInvestments
7
Supporting medical research with
no compromise to shareholders
$100m+ Donated to life-changing medical
research collectively with Sohn
Hearts & Minds since 2016
20+ Partnerships with world class
research organisations
30+ Breakthroughs across major
diseases
10+ Disease groups including cancer,
brain, rare disease & mental health
Returns that do more
Hearts& MindsInvestments
Cardiac Risk Prediction
Developing the world's first personalised
cardiac risk prediction tool, giving clinicians
the ability to intervene before a heart attack
occurs.
Youth Self-Harm Prevention
The largest youth self-harm prevention trial
in the world — 4,000 students across 80 NSW
schools — with potential to reach 1.2 million
young Australians.
Translating CAR-T Cell Therapy
Moving CAR-T cell immunotherapy from
research bench to Australian cancer
patients, making the most significant
advance in cancer treatment more
accessible.
Indigenous Diabetes
A landmark trial bringing evidence-based
diabetes care to remote Indigenous
communities, where the condition strikes at
ten times the national rate
Some Highlights:
Advancing Genomics
Building a more inclusive genomic database
representative of all Australians, improving
diagnosis and treatment regardless of
background.
Restoring Movement
Neurostimulation trials giving 20,000+ spinal
cord injury patients renewed hope, restoring
movement and treatment pathways.
Hearts & Minds Group
8 Hearts& MindsInvestments
Expanding the Hearts & Minds philanthropic
platform which benefits HM1 shareholders
through reduced costs.
HM1
GLOBAL EQUITIES
HM2
GLOBAL INCOME
HM3
AUSTRALIAN EQUITIES
Listed / Retail Unlisted / Wholesale only Unlisted / Retail
9
Introducing new “Red Flags” screen to enhance
investment process
We have partnered with Plato to review the HM1 portfolio against their
proprietary red flag database and help optimise portfolio weightings.
The red flag database has been built over decades of research into
distressed companies and common precursors to value destruction. The
screen runs across six categories, with forensic accounting representing
the largest share (33%).
HM1 Investment Process:
Any company that has 8 or more red flags is excluded from the HM1
portfolio.
As a concentrated global fund, there are always high conviction ideas that
score well, we don't need to compromise.
We are grateful to Plato Investment Management for sharing their
proprietary red flag methodology with HM1 and being part of our
mission to generate strong investment performance whilst funding
medical research.
-15.0%
-10.0%
-5.0%
0.0%
5.0%
10.0%
8 or more 7 5-6 4 3-2 0 Market
Source: Plato Investment Management, MSCI World All Cap Universe, 1/1997–12/2024.
Companies with 8+ redflags significantly underperform
Average annual return by red flag count
Companies with 8+ red
flags underperform by -13%
Six FlagCategories
Forensic
Accounting (33%)
Governance
(12%)
Market Dynamics
(13%)
Management
Behaviour (12%)
Financial Distress
(12%)
Environmental,
Renumeration &
Social Factors (18%)
9 Hearts& MindsInvestments
Partnership with Plato
Investment Management
HM1 Core Portfolio
10 Hearts& MindsInvestments
Core Fund Managers
Hamish Corlett
TDM Growth Partners
Nick Munro
Munro Partners
Tom Naughton
Prusik Investment Management
Alan Pullen
Magellan Investment Partners
Will Vicars
Caledonia Investments
Top 10 Core Holdings
30 June 2026
HM1 2025 Conference Portfolio & Stock Picks
11 Hearts& MindsInvestments
Beeneet Kothari
Tekne Capital Mgmt (USA)
ACM Research Inc
Dan Loeb
Third Point (USA)
Live Nation Entertainment Inc
Emerson Moore
Ampfield Investments (USA)
Puulio
Mohammed Anjarwala
Advent Global Opportunities (USA)
Heidelberg Materials AG
Ben Hensman
Square Peg
Monday.com
Peter Rutter
Life Cycle Investment Partners (UK)
Steel Dynamics Inc
Qiao Ma
Munro Partners
TKO GroupHoldings
Robert Mullin
Marathon Resources Advisors (USA)
Slb
Samir Mehta
J O Hambro Capital Mgmt (SG)
PB Fintech
Vihari Ross
Antipodes Partners
Brookdale Senior Living
Eric Wong
Stillpoint Investments (USA)
Morimatsu International Holdings
HM1 2026 Conference Portfolio & Stock Picks
12 Hearts& MindsInvestments
Jeremy Bond
Terra Capital
G MiningVentures
Ravi Chopra
Azora Capital (USA)
LPL Financial
Andrew Curtayne
Milford Asset Management (USA)
ASML
Ross Cameron
Northcape Capital
Coway
Samantha D'Amore
Cymer Capital (USA)
Fast Retailing
Robert Mullin
Marathon Resources Advisors (USA)
Harbour Energy
John Pinkel
Indus Capital (USA)
Kotobuki Spirits
Vihari Ross
Antipodes Partners
The Walt Disney Company
John Wylie
EFM Asset Management
Nvidia
HM1 Investment Performance
13 Hearts& MindsInvestments
HM1 Investment Performance is calculated after expenses and before Australian taxes. Inception 14 Nov 2018. Past performance is not a reliable indicator of future returns.
to 31 October 2026
1 month 6 months 1 year
3 years
per annum
Since inception
per annum
Investment Performance -2.59% 4.58% -8.64% 13.98% 9.43%
For your questions, participation and continued support of HM1.
19 November 2026
Thank you
Share your feedback
Discover